Brief: Enorama Pharma Q3 Operating Loss Widens To SEK 12.3 Mln
19/11/2025 13:28
Nov 19 (Reuters) - Enorama Pharma AB ERMA.ST: Q3 NET SALES -193 (7,481) THOUSAND SEK Q3 OPERATING PROFIT -12,339 (-4,476) THOUSAND SEK Source text: ID:nWkr6mbQZX Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO